Volume 4, Number 3 (March 2006)

Bench to Bedside

115

  

Cancer-Associated Thrombosis: Focus on Extended Therapy With Dalteparin
Rodger L. Bick, MD, PhD, FACP

Division of Hematology/Oncology, Department of Medicine, The University of Texas Southwestern Medical Center, Dallas

abstract full text 178 kb

 

PEER VIEWPOINTS
The Role of Low-Molecular-Weight Heparins in Treating Thrombosis
Agnes Y. Y. Lee, MD, MSc, FRCPC, Department of Medicine, McMaster University, Hamilton, Ontario, Canada

full text 59 kb

 

Low-Molecular-Weight Heparins for the Long-Term Treatment of Cancer Patients With Venous Thromboembolism
Paolo Prandoni, MD, PhD, Department of Medical and Surgical Sciences, University of Padua, Padua, Italy

full text 59 kb

Original Research

129

  

Weekly Epoetin Alfa Treatment of Anemia in Patients With Cancer Not Undergoing Therapy
Daniel Shasha, MD, and Denise Williams, MD

Blitman Department of Radiation Oncology, Beth Israel Medical Center, New York, New York; and Oncology Therapeutic Area, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, New Jersey

abstract full text 184 kb

139

  

A Pilot Study to Assess the Influence of Tai Chi Chuan on Functional Capacity Among Breast Cancer Survivors
Karen M. Mustian, PhD, Jeffrey A. Katula, PhD, MA, and Hongwei Zhao, DSc

Department of Radiation Oncology, University of Rochester School of Medicine and Dentistry, James P. Wilmot Cancer Center, Rochester, New York; Department of Health & Exercise Science, Wake Forest University, Winston-Salem, North Carolina; and Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, James P. Wilmot Cancer Center, Rochester, New York

abstract full text 195 kb

Commentary

147

  

If at First You Don’t Succeed, Don’t Quit, Try Again: The Centers for Medicare and Medicaid Services Demonstration Project on Quality of Care—2005 and 2006
Linda S. Elting, DrPH, Barry V. Fortner, PhD, Linda Bosserman, MD, FACP, Arthur C. Houts, PhD, and Lee Schwartzberg, MD, FACP

Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston; Supportive Oncology Services, Inc., Memphis, Tennessee; Wilshire Oncology Group, Inc., Pomona, California; and The West Clinic, Memphis, Tennessee

survey 29 kb full text 93 kb

How We Do It

153

  

How to Keep Your Patients Moving
Lisa Hoffman, MA

Solo Fitness, Inc., New York, New York

table 2 57 kb full text 294 kb

How We Say It

112

  

The Talk
Nancy Cahners

Boston, Massachusetts

full text 44 kb

Letters to the Editor

111

  

Analgesic Effect of Gefitinib in the Treatment of Non-Small Cell Lung Cancer
Natalie Moryl, MD, Eugenie A. Obbens, MD, PhD, Obinna Henry Ozigbo, MD, and Mark G. Kris, MD

Memorial Sloan-Kettering Cancer Center, New York, and Methodist Hospital, Brooklyn, New York

full text 50 kb

© 2006 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.